Pharma & Healthcare
Global Short Bowel Syndrome (SBS) Drugs Market Research Report 2025
- Aug 30, 25
- ID: 480344
- Pages: 79
- Figures: 81
- Views: 5
Report Scope
This report aims to provide a comprehensive presentation of the global market for Short Bowel Syndrome (SBS) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Short Bowel Syndrome (SBS) Drugs.
The Short Bowel Syndrome (SBS) Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Short Bowel Syndrome (SBS) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Sale Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Short Bowel Syndrome (SBS) Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sale Channel, and by regions.
By Company
Merck
Takeda
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma
Segment by Type
Glucagon-Like Peptide-2 (GLP-2)
Growth Hormone
Glutamine
Other
Segment by Sale Channel
Hospitals
Clinics
Retail Pharmacies
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Short Bowel Syndrome (SBS) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Short Bowel Syndrome (SBS) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Short Bowel Syndrome (SBS) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Short Bowel Syndrome (SBS) Drugs.
The Short Bowel Syndrome (SBS) Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Short Bowel Syndrome (SBS) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Sale Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Short Bowel Syndrome (SBS) Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sale Channel, and by regions.
By Company
Merck
Takeda
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma
Segment by Type
Glucagon-Like Peptide-2 (GLP-2)
Growth Hormone
Glutamine
Other
Segment by Sale Channel
Hospitals
Clinics
Retail Pharmacies
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Short Bowel Syndrome (SBS) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Short Bowel Syndrome (SBS) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Short Bowel Syndrome (SBS) Drugs Market Overview
1.1 Product Definition
1.2 Short Bowel Syndrome (SBS) Drugs by Type
1.2.1 Global Short Bowel Syndrome (SBS) Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Glucagon-Like Peptide-2 (GLP-2)
1.2.3 Growth Hormone
1.2.4 Glutamine
1.2.5 Other
1.3 Short Bowel Syndrome (SBS) Drugs by Sale Channel
1.3.1 Global Short Bowel Syndrome (SBS) Drugs Market Value by Sale Channel (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Retail Pharmacies
1.4 Global Short Bowel Syndrome (SBS) Drugs Market Size Estimates and Forecasts
1.4.1 Global Short Bowel Syndrome (SBS) Drugs Revenue 2020-2031
1.4.2 Global Short Bowel Syndrome (SBS) Drugs Sales 2020-2031
1.4.3 Global Short Bowel Syndrome (SBS) Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Short Bowel Syndrome (SBS) Drugs Market Competition by Manufacturers
2.1 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Short Bowel Syndrome (SBS) Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Short Bowel Syndrome (SBS) Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Short Bowel Syndrome (SBS) Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Short Bowel Syndrome (SBS) Drugs, Product Type & Application
2.7 Global Key Manufacturers of Short Bowel Syndrome (SBS) Drugs, Date of Enter into This Industry
2.8 Global Short Bowel Syndrome (SBS) Drugs Market Competitive Situation and Trends
2.8.1 Global Short Bowel Syndrome (SBS) Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Short Bowel Syndrome (SBS) Drugs Players Market Share by Revenue
2.8.3 Global Short Bowel Syndrome (SBS) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Short Bowel Syndrome (SBS) Drugs Market Scenario by Region
3.1 Global Short Bowel Syndrome (SBS) Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Short Bowel Syndrome (SBS) Drugs Sales by Region: 2020-2031
3.2.1 Global Short Bowel Syndrome (SBS) Drugs Sales by Region: 2020-2025
3.2.2 Global Short Bowel Syndrome (SBS) Drugs Sales by Region: 2026-2031
3.3 Global Short Bowel Syndrome (SBS) Drugs Revenue by Region: 2020-2031
3.3.1 Global Short Bowel Syndrome (SBS) Drugs Revenue by Region: 2020-2025
3.3.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Region: 2026-2031
3.4 North America Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
3.4.1 North America Short Bowel Syndrome (SBS) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2031)
3.4.3 North America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
3.5.1 Europe Short Bowel Syndrome (SBS) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2031)
3.5.3 Europe Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Short Bowel Syndrome (SBS) Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
3.7.1 Latin America Short Bowel Syndrome (SBS) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2031)
3.7.3 Latin America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2020-2031)
4.1.1 Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2020-2025)
4.1.2 Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2026-2031)
4.1.3 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2020-2031)
4.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Type (2020-2031)
4.2.1 Global Short Bowel Syndrome (SBS) Drugs Revenue by Type (2020-2025)
4.2.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Type (2026-2031)
4.2.3 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Short Bowel Syndrome (SBS) Drugs Price by Type (2020-2031)
5 Segment by Sale Channel
5.1 Global Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2020-2031)
5.1.1 Global Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2020-2025)
5.1.2 Global Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2026-2031)
5.1.3 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Sale Channel (2020-2031)
5.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Sale Channel (2020-2031)
5.2.1 Global Short Bowel Syndrome (SBS) Drugs Revenue by Sale Channel (2020-2025)
5.2.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Sale Channel (2026-2031)
5.2.3 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Sale Channel (2020-2031)
5.3 Global Short Bowel Syndrome (SBS) Drugs Price by Sale Channel (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Takeda
6.2.1 Takeda Company Information
6.2.2 Takeda Description and Business Overview
6.2.3 Takeda Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Takeda Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.2.5 Takeda Recent Developments/Updates
6.3 Emmaus Medical
6.3.1 Emmaus Medical Company Information
6.3.2 Emmaus Medical Description and Business Overview
6.3.3 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.3.5 Emmaus Medical Recent Developments/Updates
6.4 Ardelyx
6.4.1 Ardelyx Company Information
6.4.2 Ardelyx Description and Business Overview
6.4.3 Ardelyx Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ardelyx Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.4.5 Ardelyx Recent Developments/Updates
6.5 Naia Pharmaceuticals
6.5.1 Naia Pharmaceuticals Company Information
6.5.2 Naia Pharmaceuticals Description and Business Overview
6.5.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.5.5 Naia Pharmaceuticals Recent Developments/Updates
6.6 Nutrinia
6.6.1 Nutrinia Company Information
6.6.2 Nutrinia Description and Business Overview
6.6.3 Nutrinia Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Nutrinia Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.6.5 Nutrinia Recent Developments/Updates
6.7 OxThera
6.7.1 OxThera Company Information
6.7.2 OxThera Description and Business Overview
6.7.3 OxThera Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 OxThera Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.7.5 OxThera Recent Developments/Updates
6.8 Sancilio Pharmaceuticals
6.8.1 Sancilio Pharmaceuticals Company Information
6.8.2 Sancilio Pharmaceuticals Description and Business Overview
6.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.8.5 Sancilio Pharmaceuticals Recent Developments/Updates
6.9 Zealand Pharma
6.9.1 Zealand Pharma Company Information
6.9.2 Zealand Pharma Description and Business Overview
6.9.3 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.9.5 Zealand Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Short Bowel Syndrome (SBS) Drugs Industry Chain Analysis
7.2 Short Bowel Syndrome (SBS) Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Short Bowel Syndrome (SBS) Drugs Production Mode & Process Analysis
7.4 Short Bowel Syndrome (SBS) Drugs Sales and Marketing
7.4.1 Short Bowel Syndrome (SBS) Drugs Sales Channels
7.4.2 Short Bowel Syndrome (SBS) Drugs Distributors
7.5 Short Bowel Syndrome (SBS) Drugs Customer Analysis
8 Short Bowel Syndrome (SBS) Drugs Market Dynamics
8.1 Short Bowel Syndrome (SBS) Drugs Industry Trends
8.2 Short Bowel Syndrome (SBS) Drugs Market Drivers
8.3 Short Bowel Syndrome (SBS) Drugs Market Challenges
8.4 Short Bowel Syndrome (SBS) Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Short Bowel Syndrome (SBS) Drugs by Type
1.2.1 Global Short Bowel Syndrome (SBS) Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Glucagon-Like Peptide-2 (GLP-2)
1.2.3 Growth Hormone
1.2.4 Glutamine
1.2.5 Other
1.3 Short Bowel Syndrome (SBS) Drugs by Sale Channel
1.3.1 Global Short Bowel Syndrome (SBS) Drugs Market Value by Sale Channel (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Retail Pharmacies
1.4 Global Short Bowel Syndrome (SBS) Drugs Market Size Estimates and Forecasts
1.4.1 Global Short Bowel Syndrome (SBS) Drugs Revenue 2020-2031
1.4.2 Global Short Bowel Syndrome (SBS) Drugs Sales 2020-2031
1.4.3 Global Short Bowel Syndrome (SBS) Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Short Bowel Syndrome (SBS) Drugs Market Competition by Manufacturers
2.1 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Short Bowel Syndrome (SBS) Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Short Bowel Syndrome (SBS) Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Short Bowel Syndrome (SBS) Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Short Bowel Syndrome (SBS) Drugs, Product Type & Application
2.7 Global Key Manufacturers of Short Bowel Syndrome (SBS) Drugs, Date of Enter into This Industry
2.8 Global Short Bowel Syndrome (SBS) Drugs Market Competitive Situation and Trends
2.8.1 Global Short Bowel Syndrome (SBS) Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Short Bowel Syndrome (SBS) Drugs Players Market Share by Revenue
2.8.3 Global Short Bowel Syndrome (SBS) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Short Bowel Syndrome (SBS) Drugs Market Scenario by Region
3.1 Global Short Bowel Syndrome (SBS) Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Short Bowel Syndrome (SBS) Drugs Sales by Region: 2020-2031
3.2.1 Global Short Bowel Syndrome (SBS) Drugs Sales by Region: 2020-2025
3.2.2 Global Short Bowel Syndrome (SBS) Drugs Sales by Region: 2026-2031
3.3 Global Short Bowel Syndrome (SBS) Drugs Revenue by Region: 2020-2031
3.3.1 Global Short Bowel Syndrome (SBS) Drugs Revenue by Region: 2020-2025
3.3.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Region: 2026-2031
3.4 North America Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
3.4.1 North America Short Bowel Syndrome (SBS) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2031)
3.4.3 North America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
3.5.1 Europe Short Bowel Syndrome (SBS) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2031)
3.5.3 Europe Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Short Bowel Syndrome (SBS) Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
3.7.1 Latin America Short Bowel Syndrome (SBS) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2031)
3.7.3 Latin America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2020-2031)
4.1.1 Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2020-2025)
4.1.2 Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2026-2031)
4.1.3 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2020-2031)
4.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Type (2020-2031)
4.2.1 Global Short Bowel Syndrome (SBS) Drugs Revenue by Type (2020-2025)
4.2.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Type (2026-2031)
4.2.3 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Short Bowel Syndrome (SBS) Drugs Price by Type (2020-2031)
5 Segment by Sale Channel
5.1 Global Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2020-2031)
5.1.1 Global Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2020-2025)
5.1.2 Global Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2026-2031)
5.1.3 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Sale Channel (2020-2031)
5.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Sale Channel (2020-2031)
5.2.1 Global Short Bowel Syndrome (SBS) Drugs Revenue by Sale Channel (2020-2025)
5.2.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Sale Channel (2026-2031)
5.2.3 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Sale Channel (2020-2031)
5.3 Global Short Bowel Syndrome (SBS) Drugs Price by Sale Channel (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Takeda
6.2.1 Takeda Company Information
6.2.2 Takeda Description and Business Overview
6.2.3 Takeda Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Takeda Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.2.5 Takeda Recent Developments/Updates
6.3 Emmaus Medical
6.3.1 Emmaus Medical Company Information
6.3.2 Emmaus Medical Description and Business Overview
6.3.3 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.3.5 Emmaus Medical Recent Developments/Updates
6.4 Ardelyx
6.4.1 Ardelyx Company Information
6.4.2 Ardelyx Description and Business Overview
6.4.3 Ardelyx Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ardelyx Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.4.5 Ardelyx Recent Developments/Updates
6.5 Naia Pharmaceuticals
6.5.1 Naia Pharmaceuticals Company Information
6.5.2 Naia Pharmaceuticals Description and Business Overview
6.5.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.5.5 Naia Pharmaceuticals Recent Developments/Updates
6.6 Nutrinia
6.6.1 Nutrinia Company Information
6.6.2 Nutrinia Description and Business Overview
6.6.3 Nutrinia Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Nutrinia Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.6.5 Nutrinia Recent Developments/Updates
6.7 OxThera
6.7.1 OxThera Company Information
6.7.2 OxThera Description and Business Overview
6.7.3 OxThera Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 OxThera Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.7.5 OxThera Recent Developments/Updates
6.8 Sancilio Pharmaceuticals
6.8.1 Sancilio Pharmaceuticals Company Information
6.8.2 Sancilio Pharmaceuticals Description and Business Overview
6.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.8.5 Sancilio Pharmaceuticals Recent Developments/Updates
6.9 Zealand Pharma
6.9.1 Zealand Pharma Company Information
6.9.2 Zealand Pharma Description and Business Overview
6.9.3 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.9.5 Zealand Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Short Bowel Syndrome (SBS) Drugs Industry Chain Analysis
7.2 Short Bowel Syndrome (SBS) Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Short Bowel Syndrome (SBS) Drugs Production Mode & Process Analysis
7.4 Short Bowel Syndrome (SBS) Drugs Sales and Marketing
7.4.1 Short Bowel Syndrome (SBS) Drugs Sales Channels
7.4.2 Short Bowel Syndrome (SBS) Drugs Distributors
7.5 Short Bowel Syndrome (SBS) Drugs Customer Analysis
8 Short Bowel Syndrome (SBS) Drugs Market Dynamics
8.1 Short Bowel Syndrome (SBS) Drugs Industry Trends
8.2 Short Bowel Syndrome (SBS) Drugs Market Drivers
8.3 Short Bowel Syndrome (SBS) Drugs Market Challenges
8.4 Short Bowel Syndrome (SBS) Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Short Bowel Syndrome (SBS) Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Short Bowel Syndrome (SBS) Drugs Market Value by Sale Channel (2024 VS 2031) & (US$ Million)
Table 3. Global Short Bowel Syndrome (SBS) Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Short Bowel Syndrome (SBS) Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Short Bowel Syndrome (SBS) Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Short Bowel Syndrome (SBS) Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Short Bowel Syndrome (SBS) Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Short Bowel Syndrome (SBS) Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Short Bowel Syndrome (SBS) Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Short Bowel Syndrome (SBS) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Bowel Syndrome (SBS) Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Short Bowel Syndrome (SBS) Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Short Bowel Syndrome (SBS) Drugs Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Short Bowel Syndrome (SBS) Drugs Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Short Bowel Syndrome (SBS) Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Short Bowel Syndrome (SBS) Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Short Bowel Syndrome (SBS) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Short Bowel Syndrome (SBS) Drugs Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Short Bowel Syndrome (SBS) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Short Bowel Syndrome (SBS) Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Short Bowel Syndrome (SBS) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) by Type (2020-2025)
Table 51. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) by Type (2026-2031)
Table 52. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Short Bowel Syndrome (SBS) Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Short Bowel Syndrome (SBS) Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Short Bowel Syndrome (SBS) Drugs Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Short Bowel Syndrome (SBS) Drugs Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) by Sale Channel (2020-2025)
Table 61. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) by Sale Channel (2026-2031)
Table 62. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Sale Channel (2020-2025)
Table 63. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Sale Channel (2026-2031)
Table 64. Global Short Bowel Syndrome (SBS) Drugs Revenue (US$ Million) by Sale Channel (2020-2025)
Table 65. Global Short Bowel Syndrome (SBS) Drugs Revenue (US$ Million) by Sale Channel (2026-2031)
Table 66. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Sale Channel (2020-2025)
Table 67. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Sale Channel (2026-2031)
Table 68. Global Short Bowel Syndrome (SBS) Drugs Price (USD/Pcs) by Sale Channel (2020-2025)
Table 69. Global Short Bowel Syndrome (SBS) Drugs Price (USD/Pcs) by Sale Channel (2026-2031)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Merck Short Bowel Syndrome (SBS) Drugs Product
Table 74. Merck Recent Developments/Updates
Table 75. Takeda Company Information
Table 76. Takeda Description and Business Overview
Table 77. Takeda Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Takeda Short Bowel Syndrome (SBS) Drugs Product
Table 79. Takeda Recent Developments/Updates
Table 80. Emmaus Medical Company Information
Table 81. Emmaus Medical Description and Business Overview
Table 82. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product
Table 84. Emmaus Medical Recent Developments/Updates
Table 85. Ardelyx Company Information
Table 86. Ardelyx Description and Business Overview
Table 87. Ardelyx Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Ardelyx Short Bowel Syndrome (SBS) Drugs Product
Table 89. Ardelyx Recent Developments/Updates
Table 90. Naia Pharmaceuticals Company Information
Table 91. Naia Pharmaceuticals Description and Business Overview
Table 92. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product
Table 94. Naia Pharmaceuticals Recent Developments/Updates
Table 95. Nutrinia Company Information
Table 96. Nutrinia Description and Business Overview
Table 97. Nutrinia Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Nutrinia Short Bowel Syndrome (SBS) Drugs Product
Table 99. Nutrinia Recent Developments/Updates
Table 100. OxThera Company Information
Table 101. OxThera Description and Business Overview
Table 102. OxThera Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. OxThera Short Bowel Syndrome (SBS) Drugs Product
Table 104. OxThera Recent Developments/Updates
Table 105. Sancilio Pharmaceuticals Company Information
Table 106. Sancilio Pharmaceuticals Description and Business Overview
Table 107. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product
Table 109. Sancilio Pharmaceuticals Recent Developments/Updates
Table 110. Zealand Pharma Company Information
Table 111. Zealand Pharma Description and Business Overview
Table 112. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product
Table 114. Zealand Pharma Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Short Bowel Syndrome (SBS) Drugs Distributors List
Table 118. Short Bowel Syndrome (SBS) Drugs Customers List
Table 119. Short Bowel Syndrome (SBS) Drugs Market Trends
Table 120. Short Bowel Syndrome (SBS) Drugs Market Drivers
Table 121. Short Bowel Syndrome (SBS) Drugs Market Challenges
Table 122. Short Bowel Syndrome (SBS) Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Short Bowel Syndrome (SBS) Drugs
Figure 2. Global Short Bowel Syndrome (SBS) Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Short Bowel Syndrome (SBS) Drugs Market Share by Type: 2024 & 2031
Figure 4. Glucagon-Like Peptide-2 (GLP-2) Product Picture
Figure 5. Growth Hormone Product Picture
Figure 6. Glutamine Product Picture
Figure 7. Other Product Picture
Figure 8. Global Short Bowel Syndrome (SBS) Drugs Market Value by Sale Channel (2020-2031) & (US$ Million)
Figure 9. Global Short Bowel Syndrome (SBS) Drugs Market Share by Sale Channel: 2024 & 2031
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Retail Pharmacies
Figure 13. Global Short Bowel Syndrome (SBS) Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Short Bowel Syndrome (SBS) Drugs Market Size (2020-2031) & (US$ Million)
Figure 15. Global Short Bowel Syndrome (SBS) Drugs Sales (2020-2031) & (K Pcs)
Figure 16. Global Short Bowel Syndrome (SBS) Drugs Average Price (USD/Pcs) & (2020-2031)
Figure 17. Short Bowel Syndrome (SBS) Drugs Report Years Considered
Figure 18. Short Bowel Syndrome (SBS) Drugs Sales Share by Manufacturers in 2024
Figure 19. Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Short Bowel Syndrome (SBS) Drugs Players: Market Share by Revenue in Short Bowel Syndrome (SBS) Drugs in 2024
Figure 21. Short Bowel Syndrome (SBS) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Short Bowel Syndrome (SBS) Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2020-2031)
Figure 24. North America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2020-2031)
Figure 28. Europe Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2020-2031)
Figure 29. Germany Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region (2020-2031)
Figure 36. China Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2020-2031)
Figure 46. Latin America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Short Bowel Syndrome (SBS) Drugs by Type (2020-2031)
Figure 56. Global Revenue Market Share of Short Bowel Syndrome (SBS) Drugs by Type (2020-2031)
Figure 57. Global Short Bowel Syndrome (SBS) Drugs Price (USD/Pcs) by Type (2020-2031)
Figure 58. Global Sales Market Share of Short Bowel Syndrome (SBS) Drugs by Sale Channel (2020-2031)
Figure 59. Global Revenue Market Share of Short Bowel Syndrome (SBS) Drugs by Sale Channel (2020-2031)
Figure 60. Global Short Bowel Syndrome (SBS) Drugs Price (USD/Pcs) by Sale Channel (2020-2031)
Figure 61. Short Bowel Syndrome (SBS) Drugs Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Short Bowel Syndrome (SBS) Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Short Bowel Syndrome (SBS) Drugs Market Value by Sale Channel (2024 VS 2031) & (US$ Million)
Table 3. Global Short Bowel Syndrome (SBS) Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Short Bowel Syndrome (SBS) Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Short Bowel Syndrome (SBS) Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Short Bowel Syndrome (SBS) Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Short Bowel Syndrome (SBS) Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Short Bowel Syndrome (SBS) Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Short Bowel Syndrome (SBS) Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Short Bowel Syndrome (SBS) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Bowel Syndrome (SBS) Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Short Bowel Syndrome (SBS) Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Short Bowel Syndrome (SBS) Drugs Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Short Bowel Syndrome (SBS) Drugs Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Short Bowel Syndrome (SBS) Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Short Bowel Syndrome (SBS) Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Short Bowel Syndrome (SBS) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Short Bowel Syndrome (SBS) Drugs Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Short Bowel Syndrome (SBS) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Short Bowel Syndrome (SBS) Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Short Bowel Syndrome (SBS) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) by Type (2020-2025)
Table 51. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) by Type (2026-2031)
Table 52. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Short Bowel Syndrome (SBS) Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Short Bowel Syndrome (SBS) Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Short Bowel Syndrome (SBS) Drugs Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Short Bowel Syndrome (SBS) Drugs Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) by Sale Channel (2020-2025)
Table 61. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) by Sale Channel (2026-2031)
Table 62. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Sale Channel (2020-2025)
Table 63. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Sale Channel (2026-2031)
Table 64. Global Short Bowel Syndrome (SBS) Drugs Revenue (US$ Million) by Sale Channel (2020-2025)
Table 65. Global Short Bowel Syndrome (SBS) Drugs Revenue (US$ Million) by Sale Channel (2026-2031)
Table 66. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Sale Channel (2020-2025)
Table 67. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Sale Channel (2026-2031)
Table 68. Global Short Bowel Syndrome (SBS) Drugs Price (USD/Pcs) by Sale Channel (2020-2025)
Table 69. Global Short Bowel Syndrome (SBS) Drugs Price (USD/Pcs) by Sale Channel (2026-2031)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Merck Short Bowel Syndrome (SBS) Drugs Product
Table 74. Merck Recent Developments/Updates
Table 75. Takeda Company Information
Table 76. Takeda Description and Business Overview
Table 77. Takeda Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Takeda Short Bowel Syndrome (SBS) Drugs Product
Table 79. Takeda Recent Developments/Updates
Table 80. Emmaus Medical Company Information
Table 81. Emmaus Medical Description and Business Overview
Table 82. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product
Table 84. Emmaus Medical Recent Developments/Updates
Table 85. Ardelyx Company Information
Table 86. Ardelyx Description and Business Overview
Table 87. Ardelyx Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Ardelyx Short Bowel Syndrome (SBS) Drugs Product
Table 89. Ardelyx Recent Developments/Updates
Table 90. Naia Pharmaceuticals Company Information
Table 91. Naia Pharmaceuticals Description and Business Overview
Table 92. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product
Table 94. Naia Pharmaceuticals Recent Developments/Updates
Table 95. Nutrinia Company Information
Table 96. Nutrinia Description and Business Overview
Table 97. Nutrinia Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Nutrinia Short Bowel Syndrome (SBS) Drugs Product
Table 99. Nutrinia Recent Developments/Updates
Table 100. OxThera Company Information
Table 101. OxThera Description and Business Overview
Table 102. OxThera Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. OxThera Short Bowel Syndrome (SBS) Drugs Product
Table 104. OxThera Recent Developments/Updates
Table 105. Sancilio Pharmaceuticals Company Information
Table 106. Sancilio Pharmaceuticals Description and Business Overview
Table 107. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product
Table 109. Sancilio Pharmaceuticals Recent Developments/Updates
Table 110. Zealand Pharma Company Information
Table 111. Zealand Pharma Description and Business Overview
Table 112. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product
Table 114. Zealand Pharma Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Short Bowel Syndrome (SBS) Drugs Distributors List
Table 118. Short Bowel Syndrome (SBS) Drugs Customers List
Table 119. Short Bowel Syndrome (SBS) Drugs Market Trends
Table 120. Short Bowel Syndrome (SBS) Drugs Market Drivers
Table 121. Short Bowel Syndrome (SBS) Drugs Market Challenges
Table 122. Short Bowel Syndrome (SBS) Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Short Bowel Syndrome (SBS) Drugs
Figure 2. Global Short Bowel Syndrome (SBS) Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Short Bowel Syndrome (SBS) Drugs Market Share by Type: 2024 & 2031
Figure 4. Glucagon-Like Peptide-2 (GLP-2) Product Picture
Figure 5. Growth Hormone Product Picture
Figure 6. Glutamine Product Picture
Figure 7. Other Product Picture
Figure 8. Global Short Bowel Syndrome (SBS) Drugs Market Value by Sale Channel (2020-2031) & (US$ Million)
Figure 9. Global Short Bowel Syndrome (SBS) Drugs Market Share by Sale Channel: 2024 & 2031
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Retail Pharmacies
Figure 13. Global Short Bowel Syndrome (SBS) Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Short Bowel Syndrome (SBS) Drugs Market Size (2020-2031) & (US$ Million)
Figure 15. Global Short Bowel Syndrome (SBS) Drugs Sales (2020-2031) & (K Pcs)
Figure 16. Global Short Bowel Syndrome (SBS) Drugs Average Price (USD/Pcs) & (2020-2031)
Figure 17. Short Bowel Syndrome (SBS) Drugs Report Years Considered
Figure 18. Short Bowel Syndrome (SBS) Drugs Sales Share by Manufacturers in 2024
Figure 19. Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Short Bowel Syndrome (SBS) Drugs Players: Market Share by Revenue in Short Bowel Syndrome (SBS) Drugs in 2024
Figure 21. Short Bowel Syndrome (SBS) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Short Bowel Syndrome (SBS) Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2020-2031)
Figure 24. North America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2020-2031)
Figure 28. Europe Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2020-2031)
Figure 29. Germany Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region (2020-2031)
Figure 36. China Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2020-2031)
Figure 46. Latin America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Short Bowel Syndrome (SBS) Drugs by Type (2020-2031)
Figure 56. Global Revenue Market Share of Short Bowel Syndrome (SBS) Drugs by Type (2020-2031)
Figure 57. Global Short Bowel Syndrome (SBS) Drugs Price (USD/Pcs) by Type (2020-2031)
Figure 58. Global Sales Market Share of Short Bowel Syndrome (SBS) Drugs by Sale Channel (2020-2031)
Figure 59. Global Revenue Market Share of Short Bowel Syndrome (SBS) Drugs by Sale Channel (2020-2031)
Figure 60. Global Short Bowel Syndrome (SBS) Drugs Price (USD/Pcs) by Sale Channel (2020-2031)
Figure 61. Short Bowel Syndrome (SBS) Drugs Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232